Panacea Biotec Limited Overview
Get informed when a big investor buys or sells
+ Follow624.96
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for PANACEABIO.BO is 624.96. That is above the Healthcare sector average of 12.15. Investors often review this figure alongside Panacea Biotec Limited's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PANACEABIO.BO currently prints 624.96 for PEG ratio, while the sector average sits near 12.15. That is roughly 5042.5% above the sector mean. Large gaps often invite a closer look at Panacea Biotec Limited's growth, margins, and balance sheet.
A PEG ratio of 624.96 for Panacea Biotec Limited is not 'good' or 'bad' on its own. Compare it with the peer average (12.15) and with PANACEABIO.BO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PANACEABIO.BO's PEG ratio (624.96), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Panacea Biotec Limited's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
